CML announced that, further to the announcement on 2 October 2023, Dr Nathan Zommer has now been appointed to the board of the Company in a non-executive capacity, effective from 1 January 2024, following completion of the normal regulatory due diligence checks.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
355 GBX | +0.71% | -6.58% | -5.08% |
Mar. 26 | CML Microsystems expects revenue growth despite weak trading | AN |
2023 | CML Appoints Dr Nathan Zommer to the Board as Non-Executive, Effective from 1 January 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.08% | 72.73M | |
+144.11% | 2,971B | |
+48.23% | 703B | |
+26.01% | 652B | |
+13.88% | 271B | |
+42.86% | 231B | |
+14.75% | 178B | |
+53.43% | 145B | |
+81.74% | 142B | |
-38.83% | 131B |
- Stock Market
- Equities
- CML Stock
- News CML Microsystems plc
- CML Appoints Dr Nathan Zommer to the Board as Non-Executive, Effective from 1 January 2024